Atossa Genetics Inc (ATOS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

107 SPRING STREET SEATTLE, WA 98104

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19.

Data as of 2021-08-02 08:23:37 -0400
Market Cap378.043 Million Shares Outstanding126.436 Million Avg 30-day Volume19.209 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.18 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.8611 52-week High/Low9.8 / 0.81 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -205.8174
Data provided by IEX Cloud
View SEC Filings from ATOS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 53 20 165.0% 13 (0.76%) 5 (0.29%) 160.0%
13F shares: 10.802 Million 1.567 Million 589.27% 4.482 Million 637.277 Thousand 603.37%
% Ownership 10.4408 3.5721 192.29% 4.3324 1.4525 198.27%
New Positions: 36 4 800.0% 8
Increased Positions 11 6 83.33% 4 2 100.0%
Closed Positions 3 8 -62.5% 2
Reduced Positions 3 3 0.0% 1 2 -50.0%
Total Calls 4.669 Million 96.3 Thousand 4748.14% 782.9 Thousand 52.4 Thousand 1394.08%
Total Puts 830.193 Thousand 43.277 Thousand 1818.32% 196.273 Thousand 21 Thousand 834.63%
PUT/CALL Ratio 0.18 0.45 -60.0% 0.25 0.4 -37.5%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ATOS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATOS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

107.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

164.6 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WEAVER GREGORY L

  • Director
0 2021-07-02 2

CHEN SHU-CHIH

  • Director
50,000 2021-05-14 1

GALLI STEPHEN J

  • Director
50,000 2021-05-14 1

REMMEL H. LAWRENCE

  • Director
50,000 2021-05-14 1

QUAY STEVEN C PRESIDENT & CEO

  • Officer
  • Director
1,900,000 2021-05-14 2

GUSE KYLE CFO, GEN COUNSEL AND SECRETARY

  • Officer
850,000 2021-05-14 1

STEINHART RICHARD I

  • Director
50,000 2021-05-14 1

YOUMANS SCOTT CHIEF OPERATING OFFICER

  • Officer
0 2015-09-01 0

DESTRO CHRISTOPHER S. SVP, SALES AND MARKETING

  • Officer
0 2015-03-16 0

SAWYER JOHN E SEE REMARKS

  • Officer
0 2015-03-16 0

CARBONARO PETER J. SR. VICE PRESIDENT, OPERATIONS

  • Officer
0 2014-05-06 0

CHEN BEN R SR. VP OF GLOB. REG. AFFAIRS

  • Officer
0 2014-04-01 0

CROSS ALEXANDER D

  • Director
88,866 2013-05-15 0

BARNHART JOHN

  • Director
0 2013-05-07 0

BENJAMIN CHRISTOPHER CHIEF FINANCIAL OFFICER

  • Officer
0 2012-11-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 4,581 $5.64 a 4,581 direct -4.1441 1.2613 14.4144 5 -4.1441 2

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 45,000 d 0 direct

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 S 107,497 $5.58 d 0 direct -4.1441 1.2613 14.4144 5 -4.1441 2

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 45,000 $2.52 a 94,581 direct -4.1441 1.2613 14.4144 5 -4.1441 2

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 45,000 d 0 direct

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 F 57,084 $6.40 d 107,497 direct -4.1441 1.2613 14.4144 5 -4.1441 2

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 45,000 $2.38 a 49,581 direct -4.1441 1.2613 14.4144 5 -4.1441 2

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 70,000 d 0 direct

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 4,581 d 0 direct

WEAVER GREGORY L - Director

2021-07-07 16:29:44 -0400 2021-07-02 M 70,000 $1.70 a 164,581 direct -4.1441 1.2613 14.4144 5 -4.1441 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 22:15:04 UTC -2.6779 2.7579 350000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 21:45:03 UTC -2.676 2.756 350000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 21:15:03 UTC -2.676 2.756 350000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 20:45:03 UTC -2.7338 2.8138 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 20:15:04 UTC -2.7338 2.8138 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 19:45:04 UTC -2.7338 2.8138 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 19:15:03 UTC -2.7338 2.8138 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 18:45:03 UTC -2.7429 2.8229 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 18:15:03 UTC -2.7429 2.8229 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 17:45:03 UTC -2.7429 2.8229 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 17:15:03 UTC -2.7429 2.8229 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 16:45:02 UTC -2.6932 2.7732 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 16:15:03 UTC -2.6932 2.7732 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 15:45:03 UTC -2.6932 2.7732 350000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 15:15:02 UTC -2.6932 2.7732 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 14:45:02 UTC -2.7212 2.8012 400000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 14:15:04 UTC -2.7212 2.8012 300000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 13:45:04 UTC -2.7212 2.8012 350000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 13:15:03 UTC -2.7212 2.8012 350000
ATOSSA THERAPEUTICS INC ATOS 2021-08-05 12:45:03 UTC -2.7212 2.8012 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ATOS -26400.0 shares, $-55704.0 2021-03-31 N-PORT

Elevate your investments